Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,419 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $239.59 | 4 | $0 (2018) |
| Melinta Therapeutics, Inc. | $197.81 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $162.63 | 3 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $149.96 | 2 | $0 (2019) |
| Mallinckrodt LLC | $120.47 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
| The Medicines Company | $93.74 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $87.77 | 1 | $0 (2018) |
| Philips Electronics North America Corporation | $70.29 | 1 | $0 (2018) |
| Relypsa, Inc. | $63.25 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.54 | 1 | Inari Medical, Inc. ($19.54) |
| 2021 | $11.36 | 1 | Inari Medical, Inc. ($11.36) |
| 2019 | $320.53 | 5 | PORTOLA PHARMACEUTICALS, INC. ($149.96) |
| 2018 | $389.90 | 6 | Melinta Therapeutics, Inc. ($92.63) |
| 2017 | $677.99 | 8 | E.R. Squibb & Sons, L.L.C. ($177.85) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: VTE | ||||||
| 06/14/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: VTE | ||||||
| 06/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $19.15 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 05/09/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $105.18 | General |
| Category: ANTIBIOTICS | ||||||
| 02/13/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 12/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2018 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $60.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2018 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | Cash or cash equivalent | $92.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: Cardiovascular | ||||||
| 03/08/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $70.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 06/27/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Cardiovascular | ||||||
| 05/10/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $63.25 | General |
| Category: Hyperkalemia | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
| 01/11/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 687 | 730 | $369,547 | $89,953 |
| 2022 | 6 | 680 | 731 | $363,281 | $89,234 |
| 2021 | 6 | 664 | 699 | $342,768 | $87,952 |
| 2020 | 7 | 747 | 812 | $377,871 | $97,450 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 262 | 278 | $185,426 | $43,548 | 23.5% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 230 | 241 | $116,644 | $29,616 | 25.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 111 | 123 | $39,975 | $10,162 | 25.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 61 | 65 | $21,320 | $5,301 | 24.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 11 | $3,578 | $711.04 | 19.9% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 12 | 12 | $2,604 | $614.24 | 23.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 231 | 244 | $162,748 | $39,185 | 24.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 264 | 286 | $138,424 | $34,632 | 25.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 80 | 92 | $30,176 | $7,783 | 25.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 56 | 60 | $19,500 | $5,119 | 26.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 34 | 34 | $7,378 | $1,525 | 20.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 15 | 15 | $5,055 | $989.08 | 19.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 315 | 338 | $163,592 | $44,876 | 27.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 189 | 195 | $130,065 | $30,734 | 23.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 58 | 61 | $19,825 | $5,367 | 27.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 34 | 37 | $12,136 | $3,198 | 26.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 49 | 49 | $10,633 | $2,507 | 23.6% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 19 | 19 | $6,517 | $1,269 | 19.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 362 | 390 | $188,760 | $49,195 | 26.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 162 | 177 | $118,059 | $29,775 | 25.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 73 | 76 | $24,700 | $6,703 | 27.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 58 | 69 | $22,632 | $6,160 | 27.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 70 | 76 | $16,492 | $3,376 | 20.5% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 11 | 12 | $3,104 | $1,408 | 45.3% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 11 | 12 | $4,124 | $833.98 | 20.2% |
About Dr. Koby Hunter, DO
Dr. Koby Hunter, DO is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1518337484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Koby Hunter, DO has received a total of $1,419 in payments from pharmaceutical and medical device companies, with $19.54 received in 2023. These payments were reported across 21 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,419).
As a Medicare-enrolled provider, Hunter has provided services to 2,778 Medicare beneficiaries, totaling 2,972 services with total Medicare billing of $364,589. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 10/04/2015
- Last Updated 10/04/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518337484
Products in Payments
- ELIQUIS (Drug) $239.59
- Orbactiv (Drug) $197.81
- XARELTO (Drug) $162.63
- ANDEXXA (Biological) $149.96
- OFIRMEV (Drug) $120.47
- XIFAXAN (Drug) $99.39
- MINOCIN IV (Drug) $93.74
- BRILINTA (Drug) $87.77
- IGT_D Peripheral (Device) $70.29
- Veltassa (Drug) $63.25
- CLEVIPREX (Drug) $60.39
- GIAPREZA (Drug) $43.13
- FLOWTRIEVER CATHETER, S (Device) $30.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117